ArticleBulletin of the World Health Organization2008
Financial resources required for tuberculosis control to achieve global targets set for 2015.
Article in Bulletin of the World Health Organization, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- A randomized controlled study of socioeconomic support to enhance tuberculosis prevention and treatment, Peru.Bulletin of the World Health Organization · 2017Trial
- Tuberculosis prevalence among university freshmen in Zhengzhou, China, during 2004-2013.African health sciences · 2018Article
- Isolated Pancreatic Tuberculosis Mimicking Pancreatic Cancer: A Diagnostic Challenge.Case reports in gastrointestinal medicine · 2018Article
- Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium.Bulletin of the World Health Organization · 2017Article
- Towards cash transfer interventions for tuberculosis prevention, care and control: key operational challenges and research priorities.BMC infectious diseases · 2016Article
- Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2015Article
- Designing and implementing a socioeconomic intervention to enhance TB control: operational evidence from the CRESIPT project in Peru.BMC public health · 2015Article
- [Nephrocalcinosis complicating miliary tuberculosis in an infant].The Pan African medical journal · 2015Article
- Article
- Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2013Review
- Article
- Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge.Deutsches Arzteblatt international · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo estimate the financial resources required to achieve the 2015 targets for global tuberculosis (TB) control, which have been set within the framework of the Millennium Development Goals (MDGs).
methodsThe Global Plan to Stop TB, 2006-2015 was developed by the Stop TB Partnership. It sets out what needs to be done to achieve the 2015 targets for global TB control, based on WHO's Stop TB Strategy. Plan costs were estimated using spreadsheet models that included epidemiological, demographic, planning and unit cost data.
findingsA total of US$ 56 billion is required during the period 2006-2015 (93% for TB-endemic countries, 7% for international technical agencies), increasing from US$ 3.5 billion in 2006 to US$ 6.7 billion in 2015. The single biggest cost (US$ 3 billion per year) is for the treatment of drug-susceptible cases in DOTS programmes. Other major costs are treatment of patients with multi- and extensively drug-resistant TB (MDR-TB and XDR-TB), collaborative TB/HIV activities, and advocacy, communication and social mobilization. Low-income countries account for 41% of total funding needs and 65% of funding needs for TB/HIV. Middle-income countries account for 72% of the funding needed for treatment of MDR-TB and XDR-TB. African countries require the largest increases in funding.
conclusionAchieving the 2015 global targets set for TB control requires a major increase in funding. To support resource mobilization, comprehensive and costed national plans that are in line with the Global Plan to Stop TB are needed, backed up by robust assessments of the funding that can be raised in each country from domestic sources and the balance that is needed from donors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.